US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist

2.720
-0.040-1.45%

Close Nov 26 16:00 ET

82.07MMarket Cap-951P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-43.21%-16.66M

0.08%-13.26M

21.01%-13.04M

50.23%-51.66M

71.44%-10.25M

56.70%-11.63M

38.62%-13.27M

15.05%-16.51M

-12.98%-103.8M

4.72%-35.88M

Net income from continuing operations

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

37.09%-98.79M

33.68%-25.17M

44.18%-22M

36.64%-25.3M

33.78%-26.32M

-24.88%-157.04M

-10.37%-37.94M

Operating gains losses

-385.87%-147.84K

---133.11K

-107.97%-53.13K

594.15%4.06M

9,932.59%3.35M

-90.79%51.71K

--0

4,338.21%666.71K

-7.94%585.52K

-72.82%33.35K

Other non cash items

----

---6.35M

----

Change In working capital

-49.18%-2.47M

-1,288.33%-2.62M

165.65%599.76K

-70.92%3.08M

252.02%5.43M

54.69%-1.65M

-98.03%220.53K

-113.83%-913.58K

234.69%10.59M

69.64%-3.57M

-Change in receivables

--0

220.27%512.43K

--0

2,349.13%512.43K

-636.21%-426.06K

-2,600.89%-512.43K

-Change in prepaid assets

-261.89%-1.02M

153.11%204.31K

-54.24%432.72K

-60.85%2.84M

250.29%1.65M

14.25%627.38K

-124.45%-384.68K

-84.84%945.61K

169.79%7.26M

87.19%-1.1M

-Change in payables and accrued expense

36.41%-1.45M

-566.78%-2.82M

107.04%167.03K

-107.29%-274.08K

292.81%3.77M

49.28%-2.28M

-93.86%605.21K

-780.42%-2.37M

52.99%3.76M

38.59%-1.96M

Cash from discontinued investing activities

Operating cash flow

-43.21%-16.66M

0.08%-13.26M

21.01%-13.04M

50.23%-51.66M

71.44%-10.25M

56.70%-11.63M

38.62%-13.27M

15.05%-16.51M

-12.98%-103.8M

4.72%-35.88M

Investing cash flow

Cash flow from continuing investing activities

318.19%16.14M

1,316.79%14.01M

-74.86%10.06M

155.67%50.45M

567.62%7.74M

-87.77%3.86M

-719.62%-1.15M

498.93%40M

136.46%19.73M

98.18%-1.66M

Net investment purchase and sale

318.19%16.14M

1,316.79%14.01M

-74.86%10.06M

155.67%50.45M

567.62%7.74M

-87.77%3.86M

-719.62%-1.15M

498.93%40M

136.46%19.73M

98.18%-1.66M

Cash from discontinued investing activities

Investing cash flow

318.19%16.14M

1,316.79%14.01M

-74.86%10.06M

155.67%50.45M

567.62%7.74M

-87.77%3.86M

-719.62%-1.15M

498.93%40M

136.46%19.73M

98.18%-1.66M

Financing cash flow

Cash flow from continuing financing activities

-89.6K

221.75K

-100.22%-98.46K

-124.02%-98.46K

-76.05%45.02M

-99.75%409.88K

Net common stock issuance

--0

----

--0

----

-76.94%42.73M

-100.44%-703.72K

Proceeds from stock option exercised by employees

----

--246.75K

--0

----

--0

-25.11%1.97M

44.78%739.97K

Net other financing activities

---89.6K

--0

---25K

-130.42%-98.46K

----

--323.63K

--373.63K

Cash from discontinued financing activities

Financing cash flow

---89.6K

--0

--221.75K

-100.22%-98.46K

-124.02%-98.46K

--0

-76.05%45.02M

-99.75%409.88K

Net cash flow

Beginning cash position

-85.58%2.09M

-95.38%1.34M

-24.17%4.09M

-87.86%5.4M

-84.25%6.7M

-61.17%14.47M

-35.70%28.89M

-87.86%5.4M

1,681.02%44.44M

271.41%42.52M

Current changes in cash

92.25%-602.47K

105.21%751.24K

-111.73%-2.76M

96.66%-1.3M

92.98%-2.61M

-247.63%-7.77M

-87.98%-14.43M

4,686.45%23.5M

-193.09%-39.05M

-212.53%-37.13M

End cash Position

-77.85%1.48M

-85.58%2.09M

-95.38%1.34M

-24.17%4.09M

-84.25%6.7M

-61.17%14.47M

-35.70%28.89M

-87.86%5.4M

Free cash flow

-43.21%-16.66M

0.08%-13.26M

21.01%-13.04M

50.23%-51.66M

71.44%-10.25M

56.70%-11.63M

38.62%-13.27M

15.05%-16.51M

-12.98%-103.8M

4.72%-35.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-43.21%-16.66M	0.08%-13.26M	21.01%-13.04M	50.23%-51.66M	71.44%-10.25M	56.70%-11.63M	38.62%-13.27M	15.05%-16.51M	-12.98%-103.8M	4.72%-35.88M
Net income from continuing operations	1.25%-21.73M	29.78%-17.77M	17.07%-21.83M	37.09%-98.79M	33.68%-25.17M	44.18%-22M	36.64%-25.3M	33.78%-26.32M	-24.88%-157.04M	-10.37%-37.94M
Operating gains losses	-385.87%-147.84K	---133.11K	-107.97%-53.13K	594.15%4.06M	9,932.59%3.35M	-90.79%51.71K	--0	4,338.21%666.71K	-7.94%585.52K	-72.82%33.35K
Other non cash items	----	----	----	----	----	----	----	----	---6.35M	----
Change In working capital	-49.18%-2.47M	-1,288.33%-2.62M	165.65%599.76K	-70.92%3.08M	252.02%5.43M	54.69%-1.65M	-98.03%220.53K	-113.83%-913.58K	234.69%10.59M	69.64%-3.57M
-Change in receivables	--0	--0	--0	220.27%512.43K	--0	--0	--0	2,349.13%512.43K	-636.21%-426.06K	-2,600.89%-512.43K
-Change in prepaid assets	-261.89%-1.02M	153.11%204.31K	-54.24%432.72K	-60.85%2.84M	250.29%1.65M	14.25%627.38K	-124.45%-384.68K	-84.84%945.61K	169.79%7.26M	87.19%-1.1M
-Change in payables and accrued expense	36.41%-1.45M	-566.78%-2.82M	107.04%167.03K	-107.29%-274.08K	292.81%3.77M	49.28%-2.28M	-93.86%605.21K	-780.42%-2.37M	52.99%3.76M	38.59%-1.96M
Cash from discontinued investing activities
Operating cash flow	-43.21%-16.66M	0.08%-13.26M	21.01%-13.04M	50.23%-51.66M	71.44%-10.25M	56.70%-11.63M	38.62%-13.27M	15.05%-16.51M	-12.98%-103.8M	4.72%-35.88M
Investing cash flow
Cash flow from continuing investing activities	318.19%16.14M	1,316.79%14.01M	-74.86%10.06M	155.67%50.45M	567.62%7.74M	-87.77%3.86M	-719.62%-1.15M	498.93%40M	136.46%19.73M	98.18%-1.66M
Net investment purchase and sale	318.19%16.14M	1,316.79%14.01M	-74.86%10.06M	155.67%50.45M	567.62%7.74M	-87.77%3.86M	-719.62%-1.15M	498.93%40M	136.46%19.73M	98.18%-1.66M
Cash from discontinued investing activities
Investing cash flow	318.19%16.14M	1,316.79%14.01M	-74.86%10.06M	155.67%50.45M	567.62%7.74M	-87.77%3.86M	-719.62%-1.15M	498.93%40M	136.46%19.73M	98.18%-1.66M
Financing cash flow
Cash flow from continuing financing activities	-89.6K	0	221.75K	-100.22%-98.46K	-124.02%-98.46K	0	0	0	-76.05%45.02M	-99.75%409.88K
Net common stock issuance	--0	----	----	--0	--0	--0	----	----	-76.94%42.73M	-100.44%-703.72K
Proceeds from stock option exercised by employees	----	----	--246.75K	--0	----	----	----	--0	-25.11%1.97M	44.78%739.97K
Net other financing activities	---89.6K	--0	---25K	-130.42%-98.46K	----	----	----	----	--323.63K	--373.63K
Cash from discontinued financing activities
Financing cash flow	---89.6K	--0	--221.75K	-100.22%-98.46K	-124.02%-98.46K	--0	--0	--0	-76.05%45.02M	-99.75%409.88K
Net cash flow
Beginning cash position	-85.58%2.09M	-95.38%1.34M	-24.17%4.09M	-87.86%5.4M	-84.25%6.7M	-61.17%14.47M	-35.70%28.89M	-87.86%5.4M	1,681.02%44.44M	271.41%42.52M
Current changes in cash	92.25%-602.47K	105.21%751.24K	-111.73%-2.76M	96.66%-1.3M	92.98%-2.61M	-247.63%-7.77M	-87.98%-14.43M	4,686.45%23.5M	-193.09%-39.05M	-212.53%-37.13M
End cash Position	-77.85%1.48M	-85.58%2.09M	-95.38%1.34M	-24.17%4.09M	-24.17%4.09M	-84.25%6.7M	-61.17%14.47M	-35.70%28.89M	-87.86%5.4M	-87.86%5.4M
Free cash flow	-43.21%-16.66M	0.08%-13.26M	21.01%-13.04M	50.23%-51.66M	71.44%-10.25M	56.70%-11.63M	38.62%-13.27M	15.05%-16.51M	-12.98%-103.8M	4.72%-35.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data